Concepedia
Statistics
Publications
15
Citations
621
H-Index
13
Active since
1999
Affiliations
Bristol-Myers Squibb (United States)(Current)
Covance (United States)
University of Colorado Colorado Springs
Q2 Solutions (United States)
Intertek (United States)
Paul Rhyne is an author at Bristol-Myers Squibb (United States) specializing in medicine, bioanalysis, and immunology.
Top concepts
MedicineImmunologyBioanalysisEngineeringPharmacologyClinical ChemistryClinical SciencesBiomedical AnalysisMolecular DiagnosticsPathology
Publications per year
1999–2019
Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ingrid K. Ruf, Paul Rhyne, Hui Yang et al. · Molecular and Cellular Biology · 1999 · 127 citations
Tumor Biology, Lymphoid Neoplasia, Cancer-associated Virus +14
Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis
Ingrid K. Ruf, Paul Rhyne, Chunying Yang et al. · Journal of Virology · 2000 · 110 citations · Full text
Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat
Charles F. Albright, Randy Dockens, Jere E. Meredith et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 63 citations
2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 3 – Lba, Biomarkers and Immunogenicity)
Susan Richards, Lakshmi Amaravadi, Renuka Pillutla et al. · Bioanalysis · 2016 · 58 citations · Full text
Engineering, White Paper, Immunology +33
The Functional Heterogeneity of Type 1 Effector T Cells in Response to Infection Is Related to the Potential for IFN-γ Production
Katrin Mayer, Katja Mohrs, Sherry R. Crowe et al. · The Journal of Immunology · 2005 · 51 citations · Full text
1–5 of 15